首页> 外文期刊>Genetika >A novel microarray gene selection and classification using intelligent dynamic grey wolf optimization
【24h】

A novel microarray gene selection and classification using intelligent dynamic grey wolf optimization

机译:智能动态灰狼优化的新型基因芯片基因选择与分类

获取原文
           

摘要

Effective diagnosis of cancer in the medical field is very important to specific treatment. Exact prediction of different cancer types will provide a better treatment and minimization of toxicity in patients. Microarray high dimensionality of gene expression dataand large number of genes against small sample size, noise and repetition in datasets are the main issues which lead to poor classification accuracy. The selection of informative genes and to reduce dimensionality, Gene Selection technique is used in Microarray. In this paper, a novel meta-heurists algorithm based on Grey Wolf Optimization (GWO) and Artificial Intelligence (AI) is combined to design a model for cancer classification. This proposed work consists of two stages. First, a filter method such as Laplacian and Fisher score, are applied to extract the significant subset of features for faster classification and then Intelligent Dynamic Grey Wolf Optimization (IDGWO) is employed to identify the relevant genes. GWO is a swarm-based algorithm selected for gene expression data classification problem, because it makes classification easy about training and testing cancer data. The significant differences between filter methods of datasets are found by using several analyses. The proposed method was applied on five benchmark datasets by considering top 100 ranked genes selected by fisher score in Lymphoma and SRBCT that had a 100% performance using the IDGWO classifier.
机译:在医学领域有效诊断癌症对于具体治疗非常重要。对不同癌症类型的精确预测将为患者提供更好的治疗方法,并最大程度地降低毒性。基因表达数据的微阵列高维性和大量基因针对小样本量,噪声和数据集中的重复性是导致分类准确性差的主要问题。为了选择信息基因并减少维数,微阵列中使用了基因选择技术。本文结合基于灰狼优化(GWO)和人工智能(AI)的新型元启发式算法,设计了癌症分类模型。这项拟议工作包括两个阶段。首先,应用诸如Laplacian和Fisher评分的过滤方法来提取特征的重要子集,以便更快地进行分类,然后采用智能动态灰狼优化(IDGWO)来识别相关基因。 GWO是针对基因表达数据分类问题而选择的一种基于群体的算法,因为它使分类易于训练和测试癌症数据。通过使用多种分析,发现数据集的过滤方法之间的显着差异。通过考虑使用淋巴瘤和SRBCT中费舍尔评分选择的排名前100位的基因(使用IDGWO分类器实现了100%的性能),将该方法应用于五个基准数据集。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号